Cart
sales@molnova.com
TPCK
CAS No. 402-71-1
TPCK( —— )
Catalog No. M21646 CAS No. 402-71-1
TPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | Get Quote |
|
| 50MG | 50 | Get Quote |
|
| 100MG | 72 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTPCK
-
NoteResearch use only, not for human use.
-
Brief DescriptionTPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.
-
DescriptionTPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorchymotrypsin-like proteases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number402-71-1
-
Formula Weight351.84
-
Molecular FormulaC17H18ClNO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (284.21 mM)
-
SMILESCc1ccc(cc1)S(=O)(=O)N[C@@H](Cc1ccccc1)C(=O)CCl
-
Chemical Name(S)-N-(4-chloro-3-oxo-1-phenylbutan-2-yl)-4-methylbenzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rana Anjum Eunice Paeet al.TPCK Inhibits AGC Kinases by Direct Activation Loop Adduction at Phenylalanine-Directed Cysteine Residues. FEBS Lett. 2012 Sep 21;586(19):3471-6.
molnova catalog
related products
-
MTIC
MTIC is the active metabolite of Temozolomide (TMZ) with anticancer and antitumor activity and is used in the study of melanoma.3'-Sialyllactose (3'-SL) sodium is a prebiotic with anti-inflammatory activity.
-
Xenalipin
Xenalipin has hypolipidemic. It reduces blood cholesterol and triglycerides in rats.
-
Lithospermate B
Lithospermate B is a natural product activates eNOS and ameliorates endothelial dysfunction in diabetes by enhancing vasodilation in addition to reducing oxidative stress, it can protecte cardiomyocytes from ischemic injury through specific inhibition of TAB1-p38 apoptosis signaling.
